A P Nayate1, J G Dubroff1, J E Schmitt1, I Nasrallah1, R Kishore1, D Mankoff1, D A Pryma2. 1. From the Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania. 2. From the Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania. daniel.pryma@uphs.upenn.edu.
Abstract
BACKGROUND AND PURPOSE: Fluorine-18 florbetapir is a recently developed β-amyloid plaque positron-emission tomography imaging agent with high sensitivity, specificity, and accuracy in the detection of moderate-to-frequent cerebral cortical β-amyloid plaque. However, the FDA has expressed concerns about the consistency of interpretation of [(18)F] florbetapir PET brain scans. We hypothesized that incorporating automated cerebral-to-whole-cerebellar standardized uptake value ratios into [(18)F] florbetapir PET brain scan interpretation would reduce this interreader variability. MATERIALS AND METHODS: This randomized, blinded-reader study used previously acquired [(18)F] florbetapir scans from 30 anonymized patients who were enrolled in the Alzheimer's Disease Neuroimaging Initiative 2. In 4 separate, blinded-reading sessions, 5 readers classified 30 cases as positive or negative for significant β-amyloid deposition either qualitatively alone or qualitatively with additional adjunct software that determined standardized uptake value ratios. A κ coefficient was used to calculate interreader agreement with and without the use of standardized uptake value ratios. RESULTS: There was complete interreader agreement on 20/30 cases of [(18)F] florbetapir PET brain scans by using qualitative interpretation and on 27/30 scans interpreted with the adjunct use of standardized uptake value ratios. The κ coefficient for the studies read with standardized uptake value ratios (0.92) was significantly higher compared with the qualitatively read studies (0.69, P = .006). CONCLUSIONS: Use of standardized uptake value ratios improves interreader agreement in the interpretation of [(18)F] florbetapir images.
BACKGROUND AND PURPOSE:Fluorine-18 florbetapir is a recently developed β-amyloid plaque positron-emission tomography imaging agent with high sensitivity, specificity, and accuracy in the detection of moderate-to-frequent cerebral cortical β-amyloid plaque. However, the FDA has expressed concerns about the consistency of interpretation of [(18)F] florbetapir PET brain scans. We hypothesized that incorporating automated cerebral-to-whole-cerebellar standardized uptake value ratios into [(18)F] florbetapir PET brain scan interpretation would reduce this interreader variability. MATERIALS AND METHODS: This randomized, blinded-reader study used previously acquired [(18)F] florbetapir scans from 30 anonymized patients who were enrolled in the Alzheimer's Disease Neuroimaging Initiative 2. In 4 separate, blinded-reading sessions, 5 readers classified 30 cases as positive or negative for significant β-amyloid deposition either qualitatively alone or qualitatively with additional adjunct software that determined standardized uptake value ratios. A κ coefficient was used to calculate interreader agreement with and without the use of standardized uptake value ratios. RESULTS: There was complete interreader agreement on 20/30 cases of [(18)F] florbetapir PET brain scans by using qualitative interpretation and on 27/30 scans interpreted with the adjunct use of standardized uptake value ratios. The κ coefficient for the studies read with standardized uptake value ratios (0.92) was significantly higher compared with the qualitatively read studies (0.69, P = .006). CONCLUSIONS: Use of standardized uptake value ratios improves interreader agreement in the interpretation of [(18)F] florbetapir images.
Authors: Dean F Wong; Paul B Rosenberg; Yun Zhou; Anil Kumar; Vanessa Raymont; Hayden T Ravert; Robert F Dannals; Ayon Nandi; James R Brasić; Weiguo Ye; John Hilton; Constantine Lyketsos; Hank F Kung; Abhinay D Joshi; Daniel M Skovronsky; Michael J Pontecorvo Journal: J Nucl Med Date: 2010-06 Impact factor: 10.057
Authors: Steven Ng; Victor L Villemagne; Sam Berlangieri; Sze-Ting Lee; Martin Cherk; Sylvia J Gong; Uwe Ackermann; Tim Saunder; Henri Tochon-Danguy; Gareth Jones; Clare Smith; Graeme O'Keefe; Colin L Masters; Christopher C Rowe Journal: J Nucl Med Date: 2007-04 Impact factor: 10.057
Authors: Henryk Barthel; Julia Luthardt; Georg Becker; Marianne Patt; Eva Hammerstein; Kristin Hartwig; Birk Eggers; Bernhard Sattler; Andreas Schildan; Swen Hesse; Philipp M Meyer; Henrike Wolf; Torsten Zimmermann; Joachim Reischl; Beate Rohde; Hermann-Josef Gertz; Cornelia Reininger; Osama Sabri Journal: Eur J Nucl Med Mol Imaging Date: 2011-05-06 Impact factor: 9.236
Authors: Christopher M Clark; Michael J Pontecorvo; Thomas G Beach; Barry J Bedell; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Julie A Schneider; Anupa Arora; Alan P Carpenter; Matthew L Flitter; Abhinay D Joshi; Michael J Krautkramer; Ming Lu; Mark A Mintun; Daniel M Skovronsky Journal: Lancet Neurol Date: 2012-06-28 Impact factor: 44.182
Authors: Keith A Johnson; Satoshi Minoshima; Nicolaas I Bohnen; Kevin J Donohoe; Norman L Foster; Peter Herscovitch; Jason H Karlawish; Christopher C Rowe; Maria C Carrillo; Dean M Hartley; Saima Hedrick; Virginia Pappas; William H Thies Journal: J Nucl Med Date: 2013-01-28 Impact factor: 10.057
Authors: Mary T Kitazono; Charles T Lau; Andrea N Parada; Pooja Renjen; Wallace T Miller Journal: AJR Am J Roentgenol Date: 2010-02 Impact factor: 3.959
Authors: V Camus; P Payoux; L Barré; B Desgranges; T Voisin; C Tauber; R La Joie; M Tafani; C Hommet; G Chételat; K Mondon; V de La Sayette; J P Cottier; E Beaufils; M J Ribeiro; V Gissot; E Vierron; J Vercouillie; B Vellas; F Eustache; D Guilloteau Journal: Eur J Nucl Med Mol Imaging Date: 2012-01-18 Impact factor: 9.236
Authors: P M Doraiswamy; R A Sperling; K Johnson; E M Reiman; T Z Wong; M N Sabbagh; C H Sadowsky; A S Fleisher; A Carpenter; A D Joshi; M Lu; M Grundman; M A Mintun; D M Skovronsky; M J Pontecorvo Journal: Mol Psychiatry Date: 2014-03-11 Impact factor: 15.992
Authors: Michael J Pontecorvo; Anupa K Arora; Marybeth Devine; Ming Lu; Nick Galante; Andrew Siderowf; Catherine Devadanam; Abhinay D Joshi; Stephen L Heun; Brian F Teske; Stephen P Truocchio; Michael Krautkramer; Michael D Devous; Mark A Mintun Journal: Eur J Nucl Med Mol Imaging Date: 2017-01-07 Impact factor: 9.236
Authors: Antoine Leuzy; Kerstin Heurling; Susan De Santi; Santiago Bullich; Oskar Hansson; Johan Lilja Journal: Am J Nucl Med Mol Imaging Date: 2020-08-25
Authors: Nicholas R Harn; Suzanne L Hunt; Jacqueline Hill; Eric Vidoni; Mark Perry; Jeffrey M Burns Journal: Clin Nucl Med Date: 2017-08 Impact factor: 7.794